Transaction · 0001437749-26-030593

Cesano Alessandra

Cesano Alessandra, DIR, reported an open-market or private sale at PUMA BIOTECHNOLOGY, INC. involving 62150.000000 shares for an estimated $566994.45. Reported holdings after the transaction were 56700.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
PBYIPUMA BIOTECHNOLOGY, INC.
Trade date
Sep 14, 2026
Filing date
Sep 17, 2026
View on SEC Insider profile
Disclosed value-$566kShares × reported price
Shares traded62.1k$9.12 per share
Holdings after56.7kDirect
% of reported position traded52.29%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 118,850 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

PBYI price since this filing

Daily closing prices, with the filing date and available return windows
PBYI · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d +3.2%30d +3.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-030593
Common Stock
Transaction date
Sep 14, 2026
Filed Sep 17, 2026, 01:06 AM · 3d delay
Shares
62,150 sh
$9.12 per share
Estimated value
-$566k
Computed from shares × price
Holdings after
56,700 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Adoption date of referenced 10b5-1(c) plan is: 06-15-2026

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.2, inclusive. The Reporting Person undertakes to provide…

  3. F3

    The Stock Option is fully vested.

Original filing · 0001437749-26-030593
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

PBYI